Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...

A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

THE Abergavenny Rotary Club has donated £2,250 to Parkinson’s UK Cymru, following fundraising events. On January 31, the club ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...

Ozzy Osbourne is struggling to walk amid his battle with Parkinson’s disease, but his singing voice is “as good as ever,” ...

A Burnley resident is highlighting three back streets in Burnley that they say are riddled with drugs and rubbish.

Anthony Quinn, 49 and from Pity Me, has now been given a groundbreaking new treatment called Produodopa. Anthony becomes one ...